Rodolfo Alejandro
Clinical trials sponsored by Rodolfo Alejandro, explained in plain language.
-
Islet transplant recipients tracked for Long-Term success
Disease control Recruiting nowThis study follows about 30 people with type 1 diabetes who previously received islet cell transplants in earlier trials. The goal is to see how long the transplanted cells continue to work and to monitor safety. Participants will need to stay on lifelong immunosuppressive medica…
Sponsor: Rodolfo Alejandro • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Can a single pill protect transplant options after islet loss?
Disease control Recruiting nowThis study looks at whether the drug Myfortic can prevent the body from developing antibodies that would make future transplants harder. It involves 18 adults with type 1 diabetes whose islet transplants have stopped working. Participants take Myfortic for two years to see if it …
Phase: NA • Sponsor: Rodolfo Alejandro • Aim: Disease control
Last updated May 04, 2026 16:31 UTC
-
What happens after an islet transplant fails? new study aims to find out
Knowledge-focused Recruiting nowThis study follows 60 people with type 1 diabetes who have had an islet transplant that no longer works. Researchers want to learn how the body's immune system changes after the transplant fails. Participants will be monitored over time to track these changes.
Sponsor: Rodolfo Alejandro • Aim: Knowledge-focused
Last updated May 17, 2026 02:57 UTC